Stockreport

New Clinical Data Support Bertilimumab Activity in Bullous Pemphigoid

IMMUNE PHARMACEUTICALS INC NE  (IMNP) 
US:NASDAQ Investor Relations: immunepharma.com/investor-relations
PDF No anti-drug antibodies observed and multidose pharmacokinetics as expected FORT LEE, N.J., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (OTCQB: IMN [Read more]